Skip to main content

Table 1 Baseline characteristics of patients stratified by baseline AST/ALT ratio

From: Association between aminotransferase/alanine aminotransferase ratio and cardiovascular disease mortality in patients on peritoneal dialysis: a multi-center retrospective study

Variables

cohort (n = 1579)

Normal group (n = 369)

High group (n = 1210)

P value

Age (years)

49.3 ± 14.6

45.8 ± 13.7

50.3 ± 14.7

< 0.001

Male (%)

874 (55.4)

276 (74.8)

598 (49.4)

< 0.001

CCI

3.87 ± 1.66

3.59 ± 1.58

3.95 ± 1.68

< 0.001

Diabetes (%)

286 (18.1)

64 (17.3)

222 (18.3)

0.700

Hypertension (%)

1014 (64.2)

244 (66.1)

770 (63.6)

0.420

Hyperlipidemia (%)

256 (16.2)

46 (12.5)

210 (17.4)

0.029

Gastrointestinal bleeding (%)

41 (2.6)

10 (2.7)

31 (2.6)

0.853

Current smoking (%)

47 (3.0)

6 (1.6)

41 (3.4)

0.113

ACEI/ARB use (%)

518 (32.8)

114 (30.9)

404 (33.4)

0.410

Calcium antagonist use (%)

1141 (72.3)

272 (73.7)

869 (1.8)

0.507

β-blocker use (%)

505 (32.0)

122 (33.1)

383 (31.7)

0.611

Diuretic use (%)

94 (6.0)

20 (5.4)

74 (6.1)

0.707

Statin use (%)

157 (9.9)

26 (7.0)

131 (10.8)

0.037

BMI (kg/m2)

22.1 ± 3.6

22.3 ± 4.5

22.0 ± 3.3

0.305

Ejection fraction (%)

60.0 ± 5.9

59.8 ± 6.6

60.0 ± 5.7

0.820

eGFR (ml/min/1.73 m2)

5.63 (4.38–8.47)

5.81 (4.31–8.93)

5.50 (4.01–8.64)

0.367

Hemoglobin (g/dL)

8.6 ± 2.0

8.6 ± 2.1

8.6 ± 2.0

0.873

Albumin (g/dL)

3.5 ± 0.5

3.5 ± 0.5

3.4 ± 0.5

0.059

AST (IU/L)

18 (14–23)

19 (13–25)

18 (14–23)

0.086

ALT (IU/L)

13 (8–20)

36 (27–56)

8 (5–11)

< 0.001

Bilirubin (mg/dL)

0.30 (0.22–0.41)

0.33 (0.27–0.40)

0.30 (0.21–0.41)

0.565

Cholesterol (mg/dL)

159 ± 60

156 ± 55

160 ± 61

0.361

Triglyceride (mg/dL)

132 ± 97

126 ± 90

133 ± 98

0.198

HDL (mg/dL)

45.4 ± 16.3

44.7 ± 17.1

45.6 ± 16.1

0.432

LDL (mg/dL)

99.0 ± 38.8

95.1 ± 37.0

100.2 ± 39.3

0.038

hs-CRP (mg/L)

4.03 (1.97–11.04)

2.25 (0.85–19.5)

4.25 (2.04–14.20)

0.209

NT-pro-BNP (pg/mL)

2017 (800–6545)

771 (412–4835)

2375 (840–5760)

0.824

24-h urine output (mL)

851 ± 534

890 ± 589

839 ± 527

0.131

  1. AST/ALT aspartate aminotransferase/alanine aminotransferase, CCI Charlson comorbidity index, ACEI/ARB angiotensin-converting enzyme inhibitor/angiotensin receptor blocker, BMI body mass index, eGFR estimated glomerular filtration rate, HDL high-density lipoprotein, LDL low-density lipoprotein, high-sensitivity C-reactive protein (hs-CRP), NT-pro-BNP N-terminal -prohormone BNP